Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a psychiatric disorder

H. Tajima (Chiba, Japan), H. Kasai (Chiba, Japan), H. Miwa (Chiba, Japan), A. Naitou (Chiba, Japan), T. Sugiura (Chiba, Japan), S. Sakao (Chiba, Japan), N. Tanabe (Chiba, Japan), K. Tatsumi (Chiba, Japan)

Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Session: Clinical aspects of pulmonary hypertension
Session type: Thematic Poster
Number: 3077
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Tajima (Chiba, Japan), H. Kasai (Chiba, Japan), H. Miwa (Chiba, Japan), A. Naitou (Chiba, Japan), T. Sugiura (Chiba, Japan), S. Sakao (Chiba, Japan), N. Tanabe (Chiba, Japan), K. Tatsumi (Chiba, Japan). Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a psychiatric disorder. 3077

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders
Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism
Year: 2020




Predictors of poor outcome in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012


Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension
Source: ERJ Open Res, 4 (4) 00100-2018; 10.1183/23120541.00100-2018
Year: 2018



Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018
Year: 2018



Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease
Source: Annual Congress 2004 - Treatment of pulmonary hypertension
Year: 2004


Osteoporosis in patients with idiopathic and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007


Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019

Prevalence of comorbid cardiovascular conditions in Russian patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 453s
Year: 2006

Relationship of anxiety and depression with sociodemographic characteristics in hospitalized patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018

Association of clinical characteristics with HLA in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Pulmonary hypertension in patients with chronic myeloproliferative disorders
Source: Eur Respir Rev 2015; 24: 400-410
Year: 2015



Clinical presentation and outcomes of venous thrombo-embolic diseases in chronic obstructive pulmonary diseases. Findings from the RIETE Registry
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010


Psychiatric co-morbidity in patients admitted with acute exacerbation of chronic pulmonary disease and its relationship with symptom severity
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Management of chronic thromboembolic pulmonary hypertension (CTEPH): A physician-based perception study
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012


Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 272-282
Year: 2015



The prognostic importance of the protease-antiprotease imbalance in development of chronic obstructive pulmonary disease comorbid with chronic pancreatitis
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J 2014; 44: 951-962
Year: 2014